Public Institution for Occupational Medicine of Sarajevo Canton, Bosnia and Herzegovina.
Medical Support Unit, Bosnalijek d.d., Bosnia and Herzegovina.
Acta Med Acad. 2022 Apr;51(1):1-13. doi: 10.5644/ama2006-124.364.
This study aimed to evaluate the efficacy and safety of lysozyme-based oral antiseptic in the therapy of non-infectious sore throat in teachers.
A non-interventional, prospective, pilot study was conducted with two examinations. The first was performed as part of a general medical examination. If a non-infectious sore throat was confirmed by clinical checkup and all other inclusion and non-exclusion criteria confirmed, patients were offered to be enrolled in the study. After signing the informed consent form, patients were advised to use lysozyme-based lozenges, six times a day, for a period of five days. A telephone call follow-up examination was performed within 24 hours from the therapy completion.
This was a pilot study involving 25 adult patients of both genders. Lysozyme-based lozenges showed positive effects in relieving the symptoms of non-infectious sore throat in teachers. At the same time, the lozenges showed excellent tolerability, and no side effects were reported during the study. 92% of patients confirmed they would take the same medicine again due to the same problem.
The results of this "proof-of-concept" study indicated that lysozyme-based antiseptic could be effective and safe in the treatment of non-infectious sore throat in teachers and should be further evaluated as treatment option in this condition.
本研究旨在评估基于溶菌酶的口腔消毒剂在教师非传染性咽痛治疗中的疗效和安全性。
进行了一项非干预性、前瞻性、试点研究,共进行了两次检查。第一次检查作为一般医学检查的一部分。如果通过临床检查和所有其他纳入和排除标准确认存在非传染性咽痛,则建议患者参加研究。在签署知情同意书后,建议患者使用基于溶菌酶的含片,每天六次,持续五天。在治疗完成后 24 小时内进行电话随访检查。
这是一项涉及 25 名成年男女患者的试点研究。基于溶菌酶的含片在缓解教师非传染性咽痛症状方面显示出积极的效果。同时,含片表现出极好的耐受性,在研究过程中没有报告任何副作用。92%的患者因同样的问题确认他们会再次服用相同的药物。
这项“概念验证”研究的结果表明,基于溶菌酶的消毒剂在治疗教师非传染性咽痛方面可能是有效和安全的,应该进一步评估作为该病症的治疗选择。